Department of Pharmacology, Physiology and Therapeutics, University of North Dakota, School of Medicine and Health Sciences, Grand Forks, ND 58203, USA.
J Neurochem. 2011 Apr;117(2):264-74. doi: 10.1111/j.1471-4159.2011.07198.x. Epub 2011 Feb 24.
Glyceryl triacetate (GTA), a compound effective at increasing circulating and tissue levels of acetate was used to treat rats subjected to a continual 28 day intra-ventricular infusion of bacterial lipopolysaccharide (LPS). This model produces a neuroinflammatory injury characterized by global neuroglial activation and a decrease in choline acetyltransferase immunoreactivity in the basal forebrain. During the LPS infusion, rats were given a daily treatment of either water or GTA at a dose of 6 g/kg by oral gavage. In parallel experiments, free-CoA and acetyl-CoA levels were measured in microwave fixed brains and flash frozen heart, liver, kidney and muscle following a single oral dose of GTA. We found that a single oral dose of GTA significantly increased plasma acetate levels by 15 min and remained elevated for up to 4 h. At 30 min the acetyl-CoA levels in microwave-fixed brain and flash frozen heart and liver were increased at least 2.2-fold. The concentrations of brain acetyl-CoA was significantly increased between 30 and 45 min following treatment and remained elevated for up to 4 h. The concentration of free-CoA in brain was significantly decreased compared to controls at 240 min. Immunohistochemical and morphological analysis demonstrated that a daily treatment with GTA significantly reduced the percentage of reactive glial fibrillary acidic protein-positive astrocytes and activated CD11b-positive microglia by 40-50% in rats subjected to LPS-induced neuroinflammation. Further, in rats subjected to neuroinflammation, GTA significantly increased the number of choline acetyltransferase (ChAT)-positive cells by 40% in the basal forebrain compared to untreated controls. These data suggest that acetate supplementation increases intermediary short chain acetyl-CoA metabolism and that treatment is potentially anti-inflammatory and neuroprotective with regards to attenuating neuroglial activation and increasing ChAT immunoreactivity in this model.
三醋酸甘油酯(GTA)是一种能有效提高循环和组织中乙酸盐水平的化合物,曾被用于治疗连续 28 天接受脑室内注射细菌脂多糖(LPS)的大鼠。该模型产生一种神经炎症性损伤,其特征是全脑神经胶质激活和基底前脑胆碱乙酰转移酶免疫反应性降低。在 LPS 输注期间,大鼠通过口服灌胃每天接受水或 GTA 治疗,剂量为 6 g/kg。在平行实验中,在单次口服 GTA 后,测量微波固定脑和快速冷冻心脏、肝脏、肾脏和肌肉中的游离 CoA 和乙酰 CoA 水平。我们发现,单次口服 GTA 可使血浆乙酸盐水平在 15 分钟内显著升高 15 分钟,并持续升高 4 小时。在 30 分钟时,微波固定脑和快速冷冻心脏和肝脏中的乙酰 CoA 水平增加了至少 2.2 倍。在治疗后 30 至 45 分钟之间,大脑乙酰 CoA 的浓度显著升高,并持续升高 4 小时。与对照组相比,大脑中的游离 CoA 浓度在 240 分钟时显著降低。免疫组织化学和形态分析表明,每日用 GTA 治疗可使 LPS 诱导的神经炎症大鼠中反应性胶质纤维酸性蛋白阳性星形胶质细胞和激活的 CD11b 阳性小胶质细胞的百分比降低 40-50%。此外,在神经炎症大鼠中,与未治疗对照组相比,GTA 可使基底前脑的胆碱乙酰转移酶(ChAT)阳性细胞数量增加 40%。这些数据表明,乙酸盐补充增加了中间短链乙酰 CoA 代谢,并且这种治疗方法具有潜在的抗炎和神经保护作用,可减轻神经胶质激活并增加该模型中的 ChAT 免疫反应性。